# OnCo record nct07389265 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07389265/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07389265", "NCT07389265" ;
  schema:name "Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer"@en ;
  schema:alternateName "CAPRI-3 GOIM"@en ;
  schema:description "A phase 3 trial of cetuximab, bevacizumab (glioblastoma use), fOLFOX (5-FU, leucovorin, oxaliplatin) and fOLFIRI (5-FU, leucovorin, irinotecan) in colorectal cancer, run by University of Campania Luigi Vanvitelli, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07389265/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07389265> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/platinum/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/bevacizumab-glioma/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/folfiri/> .